Format

Send to

Choose Destination
See comment in PubMed Commons below
Pediatrics. 2016 Sep;138(3). pii: e20154545. doi: 10.1542/peds.2015-4545. Epub 2016 Aug 25.

Initial Experience With Propranolol Treatment of Lymphatic Anomalies: A Case Series.

Author information

  • 1Departments of Surgery.
  • 2Pediatrics.
  • 3Radiology, and.
  • 4Obstetrics & Gynecology, College of Physicians and Surgeons, New York, New York; and.
  • 5Department of Surgery, University of Chicago Medicine, Chicago, Illinois.
  • 6Departments of Surgery, Obstetrics & Gynecology, College of Physicians and Surgeons, New York, New York; and cjs2002@cumc.columbia.edu.

Abstract

Lymphatic malformations (LMs) are congenital lymphatic lesions that impose significant and costly morbidities on affected patients. Treatment options are limited due to incomplete understanding of LM pathobiology. Expression of an activated β2-adrenergic receptor has been described in LM tissue, suggesting that this pathway may contribute to the clinical manifestations of LM. We hypothesized that propranolol, a β-adrenergic receptor antagonist, might improve symptoms of patients with LMs and lymphatic anomalies. A retrospective chart review of patients treated with propranolol as an adjunct therapy was conducted; analyses included demographic characteristics, clinical features, and response to propranolol. Three patients with cystic and noncystic LMs displayed clinical improvement at a minimum dose of 0.7 mg/kg/d, whereas symptomatic relapses were observed when propranolol doses dropped below this threshold. Two patients with Klippel-Trenaunay syndrome demonstrated partial clinical responses with reduced edema. The fetus of a mother treated with propranolol from a gestational age of 35 weeks through delivery displayed arrested growth of a cervicofacial LM. Our retrospective review suggests that propranolol improved symptoms in a subset of patients with lymphatic anomalies. Propranolol treatment may also limit the growth of congenital LMs in utero.

PMID:
27561730
PMCID:
PMC5005016
[Available on 2017-09-01]
DOI:
10.1542/peds.2015-4545
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center